Weight-bearing of Surgically Treated Acetabular Fractures.
Launched by HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA · Jan 22, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how early weight-bearing activities can help patients who have had surgery for acetabular fractures, which are breaks in the socket of the hip joint. The researchers want to find out if patients can start putting weight on their leg as soon as they feel ready, compared to a more cautious approach where they only touch their foot to the ground for the first 6 to 8 weeks after surgery. The study will involve 50 participants who will be divided into two groups to see which approach leads to better recovery.
To be eligible for the trial, participants should have a specific type of hip fracture that has been displaced by more than 2mm, and they need to have surgery within 21 days of their injury. They must also be willing to join the follow-up process. However, individuals with certain conditions, such as bilateral fractures (both sides) or those who cannot bear weight for any reason, will not be eligible. If you decide to participate, you can expect to be monitored closely to understand how each weight-bearing approach affects your recovery. It’s also important to note that those who choose not to be randomly assigned to a group can still participate in a separate follow-up study to help the researchers understand potential differences in treatment outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral dislocated acetabulum fracture (displacement of over 2mm in preoperative CT scan)
- • The osteosynthesis is performed during 21 days after initial trauma
- • The patient is willing to participate in the follow-up
- Exclusion Criteria:
- • Unwillingness to participate in randomisation
- • Bilateral fracture
- • Letournel \& Judet type Both column or Posterior column and wall fractures
- • Any other injury that prevents the patient from partial weight bearing
- • Open fracture of the acetabulum
- • Pathologic fracture (fragility fractures are not an exclusion criteria)
- • Prior functional disability in the pelvis or lower extremity
- • Non-Compliance due to dementia or other mental disability
- • Prior daily pain medication due to hip-pain
- • Unwillingness to accept one of the two mobilisation protocols
- • Prior hip replacement on injured side
- • BMI \> 40
About Hospital District Of Helsinki And Uusimaa
The Hospital District of Helsinki and Uusimaa (HUS) is a leading healthcare provider in Finland, renowned for its commitment to high-quality patient care and innovative medical research. As a prominent clinical trial sponsor, HUS facilitates cutting-edge studies across a wide range of medical disciplines, aiming to advance healthcare solutions and improve patient outcomes. With a robust network of hospitals and specialized units, HUS leverages its expertise and resources to support the development of new therapies and interventions, fostering collaboration among healthcare professionals, researchers, and industry partners. Through its dedication to ethical standards and rigorous scientific methodology, HUS plays a pivotal role in the evolution of clinical practice and the enhancement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Trial Officials
Jan Lindahl, MD, PhD
Study Chair
Helsinki University Central Hospital
Kristian Seppänen, MD
Principal Investigator
Helsinki University Central Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials